Surrozen (SRZN) Financials

Surrozen logo
$28.46 -2.21 (-7.21%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$28.46 -0.01 (-0.02%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Surrozen

Annual Income Statements for Surrozen

This table shows Surrozen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-33 -55 -36 -43 -64 -242
Consolidated Net Income / (Loss)
-33 -55 -36 -43 -64 -242
Net Income / (Loss) Continuing Operations
-33 -55 -36 -43 -64 -139
Total Pre-Tax Income
-33 -55 -36 -43 -44 -139
Total Operating Income
-33 -54 -44 -46 -26 -42
Total Gross Profit
0.00 0.00 13 0.00 11 3.48
Total Revenue
0.00 0.00 13 0.00 11 3.48
Operating Revenue
- - 13 0.00 11 3.48
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
33 54 57 46 36 46
Selling, General & Admin Expense
7.12 14 20 16 15 16
Research & Development Expense
26 40 37 27 21 29
Total Other Income / (Expense), net
0.09 -0.26 8.34 2.34 -19 -96
Interest & Investment Income
0.09 0.07 0.78 2.34 1.69 3.02
Other Income / (Expense), net
0.00 -0.33 7.55 0.00 -20 -99
Other Adjustments to Consolidated Net Income / (Loss)
- - - - - -103
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
- - - - - 0.00
Basic Earnings per Share
($2.05) ($2.21) ($15.56) ($21.33) ($21.67) ($32.37)
Weighted Average Basic Shares Outstanding
15.97M 24.69M 2.31M 2.02M 2.93M 7.48M
Diluted Earnings per Share
($2.05) ($2.21) ($15.56) ($21.33) ($21.67) ($32.37)
Weighted Average Diluted Shares Outstanding
15.97M 24.69M 2.31M 2.02M 2.93M 7.48M
Weighted Average Basic & Diluted Shares Outstanding
15.97M 24.69M 30.08M - 3.28M 11.49M

Quarterly Income Statements for Surrozen

This table shows Surrozen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-8.83 -51 -1.43 -2.78 -27 40 -72 -183 -128 50 -130
Consolidated Net Income / (Loss)
-8.83 -4.86 -1.43 -48 -27 40 -72 -183 -128 50 -130
Net Income / (Loss) Continuing Operations
-8.83 -4.86 -1.43 -48 -44 8.23 -31 -31 -51 11 -130
Total Pre-Tax Income
-8.83 -4.86 -1.43 -29 -44 8.23 -31 -31 -51 11 -130
Total Operating Income
-9.13 -9.05 1.23 -8.59 -9.55 -9.02 -11 -13 -10 -10 -18
Total Gross Profit
0.00 0.00 10 0.66 0.98 0.98 0.98 0.53 5.00 5.00 0.00
Total Revenue
0.00 0.00 10 0.66 0.98 0.98 0.98 0.53 5.00 5.00 0.00
Operating Revenue
0.00 0.00 10 0.66 0.98 0.98 0.98 0.53 5.00 5.00 0.00
Total Cost of Revenue
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Operating Expenses
9.13 9.05 8.77 9.25 11 10 12 13 15 15 18
Selling, General & Admin Expense
3.88 3.71 3.57 3.90 3.98 3.96 4.09 4.18 6.13 6.89 6.81
Research & Development Expense
5.25 5.34 5.20 5.35 6.56 6.04 7.77 8.99 9.33 8.48 11
Total Other Income / (Expense), net
0.30 4.19 -2.67 -21 -35 17 -20 -18 -40 21 -112
Interest & Investment Income
0.39 0.49 0.43 0.39 0.30 1.03 0.91 0.79 0.91 0.94 0.91
Other Income / (Expense), net
-0.09 3.70 -3.10 -21 -35 16 -21 -19 -41 20 -113
Other Adjustments to Consolidated Net Income / (Loss)
0.00 - 0.00 - 17 32 -41 -152 -77 39 0.00
Basic Earnings per Share
($4.24) ($7.99) ($0.44) ($0.95) ($7.43) $2.55 ($8.36) ($24.49) ($11.65) $2.75 ($11.02)
Weighted Average Basic Shares Outstanding
2.08M 3.16K 3.23M 2.93M 3.63M 8.54M 8.57M 7.48M 10.95M 11.66M 11.77M
Diluted Earnings per Share
($4.24) ($7.99) ($0.44) ($0.95) ($7.43) $2.55 ($8.36) ($24.49) ($11.65) ($0.41) ($11.02)
Weighted Average Diluted Shares Outstanding
2.08M 3.16K 3.23M 2.93M 3.63M 8.54M 8.57M 7.48M 10.95M 23.15M 11.77M
Weighted Average Basic & Diluted Shares Outstanding
3.20M 3.21M 3.25M 3.28M 8.56M 8.57M 8.57M 11.49M 11.61M 11.75M 19.06M

Annual Cash Flow Statements for Surrozen

This table details how cash moves in and out of Surrozen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
5.88 -1.89 -8.40 12 -1.48 55
Net Cash From Operating Activities
-29 -49 -44 -40 -18 -30
Net Cash From Continuing Operating Activities
-29 -49 -44 -40 -18 -30
Net Income / (Loss) Continuing Operations
-33 -55 -36 -43 -64 -242
Consolidated Net Income / (Loss)
-33 -55 -36 -43 -64 -242
Depreciation Expense
1.94 2.07 1.96 1.91 1.44 0.54
Non-Cash Adjustments To Reconcile Net Income
1.63 3.89 -1.79 5.43 45 103
Changes in Operating Assets and Liabilities, net
0.05 -0.22 -8.42 -3.93 -0.84 108
Net Cash From Investing Activities
-15 -78 38 52 -0.03 -0.13
Net Cash From Continuing Investing Activities
-15 -78 38 52 -0.03 -0.13
Purchase of Property, Plant & Equipment
-0.87 -1.27 -0.73 -0.40 -0.03 -0.13
Purchase of Investments
-14 -92 -30 -28 0.00 0.00
Sale and/or Maturity of Investments
0.00 15 69 80 0.00 0.00
Net Cash From Financing Activities
50 125 -2.57 0.28 16 85
Net Cash From Continuing Financing Activities
50 125 -2.57 0.28 16 85
Issuance of Common Equity
0.00 125 0.14 0.33 16 84
Other Financing Activities, net
0.17 - 0.00 -0.00 0.04 1.07

Quarterly Cash Flow Statements for Surrozen

This table details how cash moves in and out of Surrozen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-8.75 10 -6.75 3.55 67 -11 -9.06 7.91 18 -4.92 -1.69
Net Cash From Operating Activities
-8.75 -5.61 -6.75 3.48 -9.28 -6.11 -9.04 -5.81 -12 -7.42 -4.83
Net Cash From Continuing Operating Activities
-8.75 -5.61 -6.75 3.48 -9.28 -6.11 -9.04 -5.81 -12 -7.42 -4.83
Net Income / (Loss) Continuing Operations
-8.83 -25 -1.43 -28 -27 40 -72 -183 -128 50 -130
Consolidated Net Income / (Loss)
-8.83 -25 -1.43 -28 -27 40 -72 -183 -128 50 -130
Depreciation Expense
0.39 0.39 0.34 0.32 0.29 0.14 0.06 0.05 0.07 0.05 0.05
Non-Cash Adjustments To Reconcile Net Income
1.12 19 4.50 21 35 -47 63 68 121 -56 116
Changes in Operating Assets and Liabilities, net
-1.78 0.94 -10 10 -18 0.53 -0.36 109 -5.58 -1.38 8.47
Net Cash From Investing Activities
-0.01 - - -0.02 -0.03 -0.02 -0.02 -0.06 -0.12 -0.02 -0.03
Net Cash From Continuing Investing Activities
-0.01 - - -0.02 -0.03 -0.02 -0.02 -0.06 -0.12 -0.02 -0.03
Purchase of Property, Plant & Equipment
-0.01 - - -0.02 -0.03 -0.02 -0.02 -0.06 -0.12 -0.02 -0.03
Net Cash From Financing Activities
0.00 16 -0.00 0.09 76 -5.12 0.01 14 30 2.51 3.17
Net Cash From Continuing Financing Activities
0.00 16 -0.00 0.09 76 -5.12 0.01 14 30 2.51 3.17
Other Financing Activities, net
- - - 0.04 0.00 - - 1.07 3.42 2.30 3.17

Annual Balance Sheets for Surrozen

This table presents Surrozen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
62 137 89 46 48 99
Total Current Assets
50 105 81 41 39 92
Cash & Equivalents
35 33 25 36 35 89
Accounts Receivable
- 0.00 1.98 2.15 2.54 0.21
Prepaid Expenses
1.04 3.34 3.49 2.94 1.83 2.11
Plant, Property, & Equipment, net
5.84 4.79 3.63 1.97 0.56 0.43
Total Noncurrent Assets
6.00 27 4.10 2.98 8.97 6.73
Other Noncurrent Operating Assets
6.00 5.54 4.10 2.98 8.97 6.73
Total Liabilities & Shareholders' Equity
62 137 89 46 48 99
Total Liabilities
15 27 13 8.15 70 286
Total Current Liabilities
7.28 14 9.73 7.15 7.32 9.93
Accounts Payable
1.78 2.72 0.66 0.53 0.31 0.73
Accrued Expenses
3.39 8.66 6.85 4.13 5.18 7.91
Other Current Liabilities
2.11 2.19 2.23 2.50 1.83 1.29
Total Noncurrent Liabilities
7.49 14 3.70 1.00 63 277
Other Noncurrent Operating Liabilities
7.49 14 0.33 1.00 63 277
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
47 110 76 38 -21 -188
Total Preferred & Common Equity
47 110 76 38 -21 -188
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
47 110 76 38 -21 -188
Common Stock
135 252 255 260 264 340
Retained Earnings
-88 -143 -179 -222 -285 -527

Quarterly Balance Sheets for Surrozen

This table presents Surrozen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
54 37 45 48 115 103 94 121 116 109
Total Current Assets
48 32 42 45 106 94 86 114 109 103
Cash & Equivalents
34 27 38 31 102 90 81 107 102 100
Accounts Receivable
1.98 2.13 2.11 12 2.63 2.57 2.57 5.00 5.00 0.00
Prepaid Expenses
2.95 2.60 1.76 2.08 1.73 1.28 1.96 2.04 2.36 2.53
Plant, Property, & Equipment, net
2.48 1.58 1.20 0.86 0.30 0.18 0.14 0.49 0.46 0.43
Total Noncurrent Assets
2.71 3.12 2.24 1.86 8.52 8.29 8.05 6.27 5.75 5.72
Other Noncurrent Operating Assets
2.71 3.12 2.24 1.86 8.52 8.29 8.05 6.27 5.75 5.72
Total Liabilities & Shareholders' Equity
54 37 45 48 115 103 94 121 116 109
Total Liabilities
8.44 6.58 39 42 109 56 118 399 334 445
Total Current Liabilities
6.67 6.18 5.98 6.12 11 5.74 6.53 9.57 9.01 14
Accounts Payable
0.29 0.13 0.17 0.28 0.30 0.35 0.54 0.89 1.07 0.65
Accrued Expenses
3.95 3.49 3.64 4.32 9.09 4.19 4.75 6.75 5.95 11
Other Current Liabilities
2.43 2.56 2.17 1.53 1.19 1.20 1.24 1.93 1.99 2.05
Total Noncurrent Liabilities
1.77 0.40 33 36 99 50 111 389 325 431
Other Noncurrent Operating Liabilities
0.24 0.40 33 36 99 50 111 389 325 431
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
46 30 6.06 5.67 5.67 47 -24 -278 -219 -336
Total Preferred & Common Equity
46 30 6.06 5.67 5.67 47 -24 -278 -219 -336
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
46 30 6.06 5.67 5.67 47 -24 -278 -219 -336
Common Stock
258 261 262 263 318 320 321 377 386 399
Retained Earnings
-213 -231 -256 -257 -312 -272 -344 -655 -605 -734

Annual Metrics And Ratios for Surrozen

This table displays calculated financial ratios and metrics derived from Surrozen's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 35,027,407.00 35,122,863.00 30,575,047.00 3,249,798.00 8,571,421.00
DEI Adjusted Shares Outstanding
0.00 2,335,160.00 2,341,524.00 2,038,336.00 3,249,798.00 8,571,421.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -23.40 -15.38 -21.12 -19.56 -28.24
Growth Metrics
- - - - - -
Revenue Growth
0.00% 0.00% 0.00% -100.00% 0.00% -67.37%
EBITDA Growth
0.00% -70.23% 33.92% -28.45% 0.24% -216.95%
EBIT Growth
0.00% -66.79% 32.78% -24.45% -0.34% -208.17%
NOPAT Growth
0.00% -65.79% 18.48% -3.25% 44.21% -64.81%
Net Income Growth
0.00% -67.04% 34.12% -19.55% -47.68% -280.76%
EPS Growth
0.00% -7.80% 34.12% -37.08% -1.59% -49.38%
Operating Cash Flow Growth
0.00% -67.75% 9.56% 8.57% 56.33% -71.57%
Free Cash Flow Firm Growth
0.00% 0.00% -83.42% 35.79% 229.72% 379.48%
Invested Capital Growth
0.00% -630.86% 122.70% -39.63% -3,056.92% -395.14%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -100.00% 6.55% -3.52%
EBITDA Q/Q Growth
0.00% 0.00% 27.88% -23.48% -80.26% -1.63%
EBIT Q/Q Growth
0.00% 0.00% 27.20% -23.03% -74.97% -1.42%
NOPAT Q/Q Growth
0.00% 0.00% 22.44% -19.76% 4.24% -10.64%
Net Income Q/Q Growth
0.00% 0.00% 28.25% -23.32% -164.40% -125.55%
EPS Q/Q Growth
0.00% 0.00% 28.25% -24.23% -0.37% -350.21%
Operating Cash Flow Q/Q Growth
0.00% -4.73% 20.44% -21.37% 37.97% -44.36%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -12.80% 304.64% 262.37%
Invested Capital Q/Q Growth
0.00% 0.00% 18.35% -40.88% -120.73% -164.19%
Profitability Metrics
- - - - - -
Gross Margin
0.00% 0.00% 100.00% 0.00% 100.00% 100.00%
EBITDA Margin
0.00% 0.00% -277.78% 0.00% -417.59% -4,055.91%
Operating Margin
0.00% 0.00% -354.71% 0.00% -239.69% -1,210.58%
EBIT Margin
0.00% 0.00% -294.28% 0.00% -431.12% -4,071.35%
Profit (Net Income) Margin
0.00% 0.00% -288.03% 0.00% -596.57% -6,960.77%
Tax Burden Percent
100.00% 100.00% 100.00% 99.08% 143.67% 174.70%
Interest Burden Percent
99.72% 99.87% 97.88% 94.89% 96.31% 97.87%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-69.18% -69.62% -38.78% -75.55% -767.91% 231.45%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -1,530.86% -1,225.79% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% -32.47% 0.00% -97.17% -192.35%
Return on Assets (ROA)
0.00% 0.00% -31.78% 0.00% -134.46% -328.86%
Return on Common Equity (ROCE)
-69.17% -69.62% -38.78% -75.55% -767.91% 231.45%
Return on Equity Simple (ROE_SIMPLE)
-69.18% -49.82% -47.37% -113.46% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-23 -38 -31 -32 -18 -29
NOPAT Margin
0.00% 0.00% -248.30% 0.00% -167.78% -847.41%
Net Nonoperating Expense Percent (NNEP)
-19.83% -19.20% -5.06% -20.19% -129.41% -343.37%
Return On Investment Capital (ROIC_SIMPLE)
-48.56% -34.71% -39.10% -84.48% 83.62% 15.69%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 158.61% 0.00% 141.36% 466.03%
R&D to Revenue
0.00% 0.00% 296.10% 0.00% 198.33% 844.55%
Operating Expenses to Revenue
0.00% 0.00% 454.71% 0.00% 339.69% 1,310.58%
Earnings before Interest and Taxes (EBIT)
-33 -55 -37 -46 -46 -142
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-31 -53 -35 -45 -44 -141
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 30.84 4.03 7.58 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 30.84 4.03 7.58 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 24.53 0.00 4.38 55.66
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 74.57 132.86 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 18.70 0.00 1.13 29.99
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.30 0.54
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.04 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.04 0.00 0.00 0.00
Financial Leverage
-1.04 -1.10 -1.06 -0.96 -4.27 0.59
Leverage Ratio
1.31 1.27 1.22 1.19 5.71 -0.70
Compound Leverage Factor
1.31 1.27 1.19 1.13 5.50 -0.69
Debt to Total Capital
0.00% 0.00% 4.25% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 4.25% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 95.75% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 -0.10 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 2.10 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 -0.10 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 -0.11 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 2.35 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 -0.11 0.00 0.00 0.00
Altman Z-Score
0.00 71.92 10.64 12.04 -9.96 -10.78
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
6.90 7.75 8.35 5.75 5.32 9.22
Quick Ratio
6.76 7.50 8.00 5.34 5.07 9.01
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -26 -48 -31 40 192
Operating Cash Flow to CapEx
-3,329.41% -3,846.57% -6,063.87% -10,141.46% -67,800.00% -23,628.13%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.00 0.11 0.00 0.23 0.05
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 4.54 2.53
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 2.97 0.00 8.42 6.99
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 80.38 144.29
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 80.38 144.29
Capital & Investment Metrics
- - - - - -
Invested Capital
-1.89 -14 3.13 1.89 -56 -277
Invested Capital Turnover
0.00 0.00 -2.34 0.00 -0.39 -0.02
Increase / (Decrease) in Invested Capital
0.00 -12 17 -1.24 -58 -221
Enterprise Value (EV)
0.00 3,260 234 251 12 104
Market Capitalization
0.00 3,384 307 287 47 194
Book Value per Share
$2.96 $3.13 $2.16 $1.24 ($6.58) ($21.91)
Tangible Book Value per Share
$2.96 $3.13 $2.16 $1.24 ($6.58) ($21.91)
Total Capital
47 110 79 38 -21 -188
Total Debt
0.00 0.00 3.38 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 3.38 0.00 0.00 0.00
Net Debt
-49 -124 -73 -36 -35 -89
Capital Expenditures (CapEx)
0.87 1.27 0.73 0.40 0.03 0.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-6.24 -10 -4.67 -2.06 -2.95 -7.62
Debt-free Net Working Capital (DFNWC)
43 92 72 34 32 82
Net Working Capital (NWC)
43 92 72 34 32 82
Net Nonoperating Expense (NNE)
9.75 17 4.97 11 46 213
Net Nonoperating Obligations (NNO)
-49 -124 -73 -36 -35 -89
Total Depreciation and Amortization (D&A)
1.94 2.17 2.06 1.18 1.44 0.54
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% -37.36% 0.00% -27.67% -219.04%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 572.58% 0.00% 296.73% 2,347.68%
Net Working Capital to Revenue
0.00% 0.00% 572.58% 0.00% 296.73% 2,347.68%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 ($33.15) ($15.60) ($21.33) ($21.67) ($32.37)
Adjusted Weighted Average Basic Shares Outstanding
0.00 2.34M 2.31M 2.02M 2.93M 7.48M
Adjusted Diluted Earnings per Share
$0.00 ($33.15) ($15.60) ($21.33) ($21.67) ($32.37)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 2.34M 2.31M 2.02M 2.93M 7.48M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($33.15) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 1.65M 2.01M 0.00 3.28M 11.49M
Normalized Net Operating Profit after Tax (NOPAT)
-23 -38 -31 -30 -18 -29
Normalized NOPAT Margin
0.00% 0.00% -248.30% 0.00% -167.78% -847.41%
Pre Tax Income Margin
0.00% 0.00% -288.03% 0.00% -415.23% -3,984.50%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% -7.48% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Surrozen

This table displays calculated financial ratios and metrics derived from Surrozen's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
30,575,047.00 3,198,786.00 3,205,852.00 3,249,798.00 3,281,169.00 8,562,584.00 8,570,355.00 8,571,421.00 11,486,707.00 11,610,371.00 11,753,558.00
DEI Adjusted Shares Outstanding
2,038,336.00 3,198,786.00 3,205,852.00 3,249,798.00 3,281,169.00 8,562,584.00 8,570,355.00 8,571,421.00 11,486,707.00 11,610,371.00 11,753,558.00
DEI Earnings Per Adjusted Shares Outstanding
-4.33 -15.79 -0.45 -0.85 -8.22 4.64 -8.36 -21.37 -11.10 4.32 -11.04
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -90.17% -19.39% 408.65% 408.65% -100.00%
EBITDA Growth
42.03% 49.07% 85.94% -210.00% -424.79% 247.71% -4,659.88% -7.75% -15.91% 36.85% -311.36%
EBIT Growth
37.92% 46.51% 83.21% -200.43% -385.33% 234.50% -3,790.29% -6.72% -15.29% 38.74% -310.73%
NOPAT Growth
37.43% 11.93% 111.01% 11.64% -4.61% -42.35% -983.52% -47.10% -9.48% -15.01% -62.08%
Net Income Growth
38.24% 48.18% 86.27% -443.43% -205.44% 917.15% -4,896.03% -278.15% -372.77% 26.24% -81.07%
EPS Growth
40.78% -70.73% 91.44% 78.51% -75.24% 131.91% -1,800.00% -2,477.89% -56.80% -116.08% -31.82%
Operating Cash Flow Growth
38.28% 35.87% 33.37% 147.61% -6.09% -8.95% -33.89% -266.96% -34.66% -21.30% 46.59%
Free Cash Flow Firm Growth
39.52% 403.46% 450.74% 1,031.26% 1,259.47% -91.12% 144.45% 309.50% 205.83% 10,348.28% 343.45%
Invested Capital Growth
120.45% -1,026.45% -892.03% -3,056.92% -3,472.14% -36.50% -313.69% -395.14% -301.22% -641.07% -315.81%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -93.45% 50.08% 0.00% 0.00% -46.29% 846.97% 0.00% -100.00%
EBITDA Q/Q Growth
10.06% 41.32% 69.34% -1,815.96% -52.26% 116.52% -1,087.91% 56.63% -63.79% 119.50% -1,400.39%
EBIT Q/Q Growth
6.16% 41.90% 65.17% -1,481.88% -51.59% 116.10% -1,107.55% 56.60% -63.77% 119.38% -1,407.54%
NOPAT Q/Q Growth
6.11% 0.89% 113.61% -797.40% -11.16% -34.87% 15.50% -16.11% 17.27% -41.68% -19.09%
Net Income Q/Q Growth
0.93% 44.92% 70.52% -3,277.68% 44.32% 247.37% -280.25% -155.66% 30.39% 139.35% -358.53%
EPS Q/Q Growth
4.07% -88.44% 94.49% -115.91% -682.11% 134.32% -427.84% -192.94% 52.43% 96.48% -2,587.80%
Operating Cash Flow Q/Q Growth
-19.63% 35.85% -20.34% 151.56% -366.56% 34.12% -47.88% 35.71% -114.99% 40.66% 34.89%
Free Cash Flow Firm Q/Q Growth
-42.79% 462.33% 2.14% 76.22% 77.78% -97.23% 2,712.42% 195.21% 32.77% -5.22% 19.37%
Invested Capital Q/Q Growth
50.42% -1,213.95% 20.05% -120.73% -71.55% 54.91% -142.28% -164.19% -39.01% 16.71% -35.94%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 0.00%
EBITDA Margin
0.00% 0.00% -15.23% -4,454.96% -4,519.74% 746.49% -7,374.67% -5,954.55% -1,029.94% 200.84% 0.00%
Operating Margin
0.00% 0.00% 12.32% -1,311.76% -971.62% -917.29% -1,107.32% -2,393.75% -209.12% -207.40% 0.00%
EBIT Margin
0.00% 0.00% -18.65% -4,504.12% -4,549.64% 732.55% -7,380.87% -5,963.07% -1,031.24% 199.82% 0.00%
Profit (Net Income) Margin
0.00% 0.00% -14.34% -7,394.81% -2,743.64% 4,043.34% -7,288.20% -34,689.20% -2,550.10% 1,003.54% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 166.36% 60.71% 483.18% 100.00% 596.67% 251.74% 459.12% 100.00%
Interest Burden Percent
95.82% 90.85% 76.89% 98.69% 99.34% 114.23% 98.74% 97.50% 98.23% 109.39% 99.30%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-80.66% -108.15% -93.91% -767.91% -456.32% -139.51% 1,202.41% 231.45% 251.45% 387.21% 217.30%
Cash Return on Invested Capital (CROIC)
-1,439.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% -3.66% -1,015.19% -698.79% 125.14% -374.54% -281.72% -65.62% 21.07% 0.00%
Return on Assets (ROA)
0.00% 0.00% -2.81% -1,666.72% -421.40% 690.69% -369.84% -1,638.86% -162.27% 105.83% 0.00%
Return on Common Equity (ROCE)
-80.66% -108.15% -93.91% -767.91% -456.32% -139.51% 1,202.41% 231.45% 251.45% 387.21% 217.30%
Return on Equity Simple (ROE_SIMPLE)
-124.68% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-6.39 -6.33 0.86 -6.01 -6.69 -9.02 -7.62 -8.85 -7.32 -10 -12
NOPAT Margin
0.00% 0.00% 8.62% -918.23% -680.13% -917.29% -775.13% -1,675.63% -146.38% -207.40% 0.00%
Net Nonoperating Expense Percent (NNEP)
-5.48% 3.29% -6.26% -120.16% -31.46% 76.10% -113.97% -281.58% -115.26% 62.93% -129.20%
Return On Investment Capital (ROIC_SIMPLE)
-21.21% -104.49% 15.22% 28.13% -117.83% -19.14% 32.40% 4.71% 2.63% 4.74% 3.68%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 35.68% 594.96% 404.48% 402.65% 416.48% 790.91% 122.56% 137.72% 0.00%
R&D to Revenue
0.00% 0.00% 52.00% 816.79% 667.14% 614.65% 790.84% 1,702.84% 186.56% 169.68% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 87.68% 1,411.76% 1,071.62% 1,017.29% 1,207.32% 2,493.75% 309.12% 307.40% 0.00%
Earnings before Interest and Taxes (EBIT)
-9.22 -5.35 -1.87 -30 -45 7.20 -73 -31 -52 9.99 -131
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-8.47 -4.97 -1.52 -29 -44 7.34 -72 -31 -51 10 -131
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
15.94 5.78 6.78 0.00 6.74 1.62 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
15.94 5.78 6.78 0.00 6.74 1.62 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 3.84 4.38 3.29 6.07 30.61 55.66 33.28 19.30 26.17
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 8.94 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 11.19% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
159.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.74 1.13 0.00 0.00 8.04 29.99 19.02 10.44 16.64
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.75 0.30 0.00 0.00 0.55 0.54 0.55 0.49 0.59
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.96 -1.46 -1.43 -4.27 -3.60 -2.41 6.29 0.59 0.77 1.12 0.51
Leverage Ratio
1.19 1.78 1.99 5.71 4.23 2.78 -7.96 -0.70 -0.86 -1.27 -0.57
Compound Leverage Factor
1.14 1.62 1.53 5.64 4.20 3.17 -7.86 -0.69 -0.85 -1.39 -0.56
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
35.03 -6.85 -5.90 -8.85 -3.78 -1.50 -6.06 -7.10 -7.53 -5.50 -11.93
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
5.18 6.96 7.40 5.32 10.02 16.41 13.15 9.22 11.91 12.14 7.56
Quick Ratio
4.76 6.67 7.06 5.07 9.85 16.19 12.85 9.01 11.70 11.88 7.37
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-7.95 29 29 52 92 2.56 72 212 282 267 319
Operating Cash Flow to CapEx
-124,942.86% 0.00% 0.00% 18,321.05% -34,366.67% -33,961.11% -37,666.67% -9,850.85% -10,412.50% -39,026.32% -17,881.48%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.20 0.23 0.15 0.17 0.05 0.05 0.06 0.11 0.10
Accounts Receivable Turnover
0.00 0.00 1.41 4.54 4.89 5.39 0.49 2.53 1.96 3.04 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 5.99 8.42 12.39 18.37 7.24 6.99 19.14 36.43 36.88
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 258.68 80.38 74.64 67.69 747.62 144.29 185.86 120.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 258.68 80.38 74.64 67.69 747.62 144.29 185.86 120.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2.85 -32 -25 -56 -96 -43 -105 -277 -385 -321 -436
Invested Capital Turnover
0.00 0.00 -0.90 -0.39 -0.25 -0.34 -0.06 -0.02 -0.03 -0.06 -0.04
Increase / (Decrease) in Invested Capital
1.56 -35 -29 -58 -99 -12 -80 -221 -289 -277 -331
Enterprise Value (EV)
453 -2.74 7.39 12 -63 -14 29 104 143 120 175
Market Capitalization
480 35 38 47 38 77 110 194 249 222 276
Book Value per Share
$0.99 $1.90 $1.77 ($6.58) $1.75 $5.50 ($2.74) ($21.91) ($24.21) ($18.83) ($28.55)
Tangible Book Value per Share
$0.99 $1.90 $1.77 ($6.58) $1.75 $5.50 ($2.74) ($21.91) ($24.21) ($18.83) ($28.55)
Total Capital
30 6.06 5.67 -21 5.67 47 -24 -188 -278 -219 -336
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-27 -38 -31 -35 -102 -90 -81 -89 -107 -102 -100
Capital Expenditures (CapEx)
0.01 0.00 0.00 0.02 0.03 0.02 0.02 0.06 0.12 0.02 0.03
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1.45 -2.11 8.15 -2.95 -6.22 -1.90 -2.00 -7.62 -2.53 -1.65 -11
Debt-free Net Working Capital (DFNWC)
26 36 39 32 95 88 79 82 104 100 89
Net Working Capital (NWC)
26 36 39 32 95 88 79 82 104 100 89
Net Nonoperating Expense (NNE)
2.44 -1.47 2.30 42 20 -49 64 174 120 -61 117
Net Nonoperating Obligations (NNO)
-27 -38 -31 -35 -102 -90 -81 -89 -107 -102 -100
Total Depreciation and Amortization (D&A)
0.75 0.39 0.34 0.32 0.29 0.14 0.06 0.05 0.07 0.05 0.05
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 81.54% -27.67% -53.41% -15.04% -55.58% -219.04% -33.71% -14.33% -105.22%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 391.66% 296.73% 819.98% 701.15% 2,201.22% 2,347.68% 1,392.90% 872.11% 847.98%
Net Working Capital to Revenue
0.00% 0.00% 391.66% 296.73% 819.98% 701.15% 2,201.22% 2,347.68% 1,392.90% 872.11% 847.98%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($4.24) ($7.99) ($0.44) ($0.95) ($7.43) $2.55 ($8.36) ($24.49) ($11.65) $2.75 ($11.02)
Adjusted Weighted Average Basic Shares Outstanding
2.08M 3.16M 3.23M 2.93M 3.63M 8.54K 8.57M 7.48M 10.95M 11.66M 11.77M
Adjusted Diluted Earnings per Share
($4.24) ($7.99) ($0.44) ($0.95) ($7.43) $2.55 ($8.36) ($24.49) ($11.65) ($0.41) ($11.02)
Adjusted Weighted Average Diluted Shares Outstanding
2.08M 3.16M 3.23M 2.93M 3.63M 8.54K 8.57M 7.48M 10.95M 23.15M 11.77M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 ($0.95) $0.00 $0.00 $0.00 ($24.49) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
3.20M 3.21M 3.25M 3.28M 8.56M 8.57M 8.57M 11.49M 11.61M 11.75M 19.06M
Normalized Net Operating Profit after Tax (NOPAT)
-6.39 -6.33 0.86 -6.01 -6.69 -6.31 -7.62 -8.85 -7.32 -7.26 -12
Normalized NOPAT Margin
0.00% 0.00% 8.62% -918.23% -680.13% -642.11% -775.13% -1,675.63% -146.38% -145.18% 0.00%
Pre Tax Income Margin
0.00% 0.00% -14.34% -4,445.04% -4,519.53% 836.83% -7,288.20% -5,813.83% -1,013.00% 218.58% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Surrozen’s latest statements show a company with substantial cash reserves and a recent revenue improvement, but it remains dependent on financing and continues to generate operating losses. The Q2 2026 results also include significant non-operating and non-cash items, making headline net income less representative of the underlying business.

  • Revenue improved materially in 2026. Quarterly revenue increased to $5.0 million in both Q1 and Q2 2026, compared with $528,000 in Q4 2025 and $983,000 in Q3 2025. However, investors should determine whether this revenue represents recurring commercial activity or milestone-related payments.
  • Cash remains a meaningful financial resource. Surrozen reported $102.0 million of cash and equivalents at June 30, 2026. Although cash declined by $4.9 million during Q2, the balance provides near-term funding for research and development and other operations.
  • Operating cash burn improved sequentially. Net cash used in operating activities declined from $12.5 million in Q1 2026 to $7.4 million in Q2. The Q2 burn was also lower than the $9.0 million used in Q3 2025 and $5.8 million used in Q4 2025, although quarterly volatility remains high.
  • Operating expenses were relatively stable in Q2. Total operating expenses fell slightly to $15.4 million from $15.5 million in Q1 2026, while research and development spending declined to $8.5 million from $9.3 million. Continued investment in R&D could support future pipeline development.
  • Interest income provides a modest offset to cash burn. Interest and investment income increased to $938,000 in Q2 2026 from $912,000 in Q1 and $788,000 in Q4 2025, reflecting the benefit of Surrozen’s cash balance.
  • Q2 net income was boosted by unusual items. Surrozen reported consolidated net income of $50.2 million, but operating income was a loss of $10.4 million. Net income benefited from $21.3 million of other income and $39.2 million of other adjustments, while the cash flow statement included a $56.3 million negative non-cash adjustment. Investors should focus on operating results and cash flow rather than the reported profit alone.
  • Capital expenditures are minimal. Property, plant and equipment purchases were only $19,000 in Q2 2026 and $120,000 in Q1. This limits near-term capital requirements, but it also reflects the asset-light nature of the business and does not address the company’s ongoing research funding needs.
  • The statements contain restated historical figures. Several 2024 and 2025 income statement and cash flow figures are identified as restated, and certain earnings-per-share data appear inconsistent with reported share counts. Investors should rely on the latest filings when comparing historical trends.
  • Surrozen remains unprofitable on an operating basis. The company recorded operating losses in every recent quarter provided, including a $10.4 million loss in Q2 2026. Revenue of $5.0 million covered only about one-third of quarterly operating expenses.
  • Operating cash flow remains negative. Surrozen used $7.4 million in operating cash during Q2 2026, continuing a multi-year pattern of cash consumption. At the Q2 burn rate, the cash balance could support operations for several quarters, but spending levels and future development costs may change significantly.
  • Shareholders’ equity is deeply negative. Total equity deteriorated from positive $47.1 million at June 30, 2025, to negative $218.7 million at June 30, 2026. Retained earnings were negative $604.6 million, indicating substantial accumulated losses and a weak balance-sheet position.
  • Liabilities substantially exceed assets. Total liabilities reached $334.3 million at June 30, 2026, including $325.3 million of noncurrent liabilities, compared with total assets of $115.6 million. This creates significant balance-sheet risk despite the company’s strong cash position.
  • Surrozen has relied heavily on equity financing. The company raised $30.3 million through financing activities in Q1 2026 and $26.9 million through common-equity issuance in Q1 2025. Continued cash burn may require additional capital raises, potentially diluting existing shareholders.
  • Per-share results remain volatile. Basic EPS swung from a loss of $11.65 in Q1 2026 to reported earnings of $2.75 in Q2, while diluted EPS was negative $0.41 in Q2. This divergence underscores the effect of unusual adjustments and share-count changes on reported earnings.

Overall, the financial statements present a mixed picture: Surrozen has more than $100 million in cash and reported a rebound in revenue, but its core operations remain loss-making, equity is negative, and liabilities are unusually high relative to assets. The most important indicators for investors are whether the $5 million quarterly revenue level can persist, whether operating cash burn continues to decline, and whether additional equity financing will be required.

11/22/26 11:27 AM ETAI Generated. May Contain Errors.

Surrozen Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Surrozen's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Surrozen's net income appears to be on a downward trend, with a most recent value of -$242.03 million in 2025, falling from -$32.72 million in 2020. The previous period was -$63.56 million in 2024. Check out Surrozen's forecast to explore projected trends and price targets.

Surrozen's total operating income in 2025 was -$42.09 million, based on the following breakdown:
  • Total Gross Profit: $3.48 million
  • Total Operating Expenses: $45.57 million

Over the last 5 years, Surrozen's total revenue changed from $0.00 in 2020 to $3.48 million in 2025, a change of 347,700,000.0%.

In the past 12 quarters, Surrozen's cash and equivalents has ranged from $27.29 million in Q1 2024 to $106.91 million in Q1 2026, and is currently $100.35 million as of their latest financial filing in Q3 2026.

Surrozen had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2020.

Over the last 5 years, Surrozen's book value per share changed from 2.96 in 2020 to -21.91 in 2025.



Financial statements for NASDAQ:SRZN last updated on 11/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners